Cannabis research these days is focused on the endogenous cannabinoid systems (ECS), discovered in 1992. The ECS is a physiological system found internally (“endo”) in all mammals. It creates natural cannabinoids (the best known are anandamide and 2AG) that help the body maintain balance, a process called homeostasis. Cannabinoids found in the cannabis plant mimic those internal cannabinoids. When our homeostasis in “out of kilter” using cannabis can help regain the body’s internal balance.
There is a great deal to learn about the ECS and scientists around the world are captivated by this newly discovered physiological wonder. In 1993 there were just 10 studies of the ECS found in PubMed, the national database for scientific research. By 2015 that number had exploded to 6,521!
Medical marijuana for children with cancer? What providers think – Scienmag: Latest Science and Health News
A study published in Pediatrics examined interdisciplinary provider perspectives on legal medical marijuana use in children with cancer. It found that 92 percent of providers were willing to help children with cancer access medical marijuana. However.. Source: Medical marijuana for children with cancer? What providers think – Scienmag: Latest Science and Health News
OBJECTIVE Cannabidiol (CBD) and Δ9-tetrahydrocannabivarin (THCV) are nonpsychoactive phytocannabinoids affecting lipid and glucose metabolism in animal models. This study set out to examine the effects of these compounds in patients with type 2 diabetes. Source: Diabetes Care
Zelda Therapeutics of Australia is developing a range of cannabinoid-based formulations to treat medical conditions. Source: Zelda Therapeutics Ltd demonstrates successful results treating autism with medicinal cannabis
U.S. medical marijuana companies are setting up shop in Israel, where fewer roadblocks mean better research – and faster results Source: How Booming Israeli Weed Industry Is Changing American Pot – Rolling Stone
By Pat Anson, Editor The U.S. Drug Enforcement Administration has approved a synthetic form of THC (tetrahydrocannabinol) – the active ingredient in marijuana that makes people “high” – as a Schedule II controlled substance. The move is the final regulatory hurdle for dronabinol (Syndros), an oral s Source: DEA Gives Final Approval to Synthetic […]
The role of nutrition in a healthy ECS Nat Neurosci. 2011 Mar;14(3):345-50. doi: 10.1038/nn.2736. Epub 2011 Jan 30. Research Support, Non-U.S. Gov’t